Suppr超能文献

[癫痫发作作为长期服用唑吡坦戒断的一种体征]

[Epileptic seizures as a sign of abstinence from chronic consumption of zolpidem].

作者信息

Barrero-Hernández F J, Ruiz-Veguilla M, López-López M I, Casado-Torres A

机构信息

Servicio de Neurología, Hospital Clínico Universitario San Cecilio, Granada, 18012, España.

出版信息

Rev Neurol. 2002;34(3):253-6.

Abstract

INTRODUCTION

Zolpidem is derived from imidazopiridine. In recent years it has been used as a non benzodiazepine hypnotic. It is a short acting inducer of sleep of similar efficacy to the benzodiazepines or zopiclone, but well tolerated and does not lead to drug abuse, rebound effects or abstinence syndromes. In this clinical note we wish to show that in spite of the descriptions in the medical literature, complications may follow long term use of zolpidem.

CLINICAL CASE

We report the case of a 50 year old woman with no clinical history of interest apart from chronic insomnia and anxiety. She had been treated with zolpidem for the previous five years, at the usual dosage. However, since this seemed to be insufficient, the dose was progressively increased until in the months before she was seen by us she was taking a total of 450 mg per day in divided doses. She had drug tolerance, abuse and dependence. After a period of 12 hours without taking zolpidem she developed an abstinence syndrome, with generalized tonic clonic seizures and a prolonged post convulsion period which improved on symptomatic anticonvulsant treatment.

CONCLUSIONS

In view of our case, and others described, we should be sceptical of the claim that zolpidem has no side effects, since it may give rise to tolerance, abuse and an abstinence syndrome. We consider that its indiscriminate use should be modified. Patients should be carefully followed up and medical prescription necessary to obtain zolpidem, as opposed to its current unrestricted availability.

摘要

引言

唑吡坦源自咪唑吡啶。近年来,它被用作非苯二氮䓬类催眠药。它是一种短效睡眠诱导剂,疗效与苯二氮䓬类药物或佐匹克隆相似,但耐受性良好,不会导致药物滥用、反跳效应或戒断综合征。在本临床记录中,我们希望表明,尽管医学文献中有相关描述,但长期使用唑吡坦可能会引发并发症。

临床病例

我们报告一例50岁女性病例,除慢性失眠和焦虑外无其他值得关注的临床病史。她在过去五年中一直按常规剂量服用唑吡坦。然而,由于这似乎效果不佳,剂量逐渐增加,直到在我们见到她之前的几个月里,她每天分多次共服用450毫克。她出现了药物耐受性、滥用和依赖性。在停用唑吡坦12小时后,她出现了戒断综合征,伴有全身性强直阵挛性发作和惊厥后长时间的恢复期,经对症抗惊厥治疗后有所改善。

结论

鉴于我们的病例以及其他已描述的病例,我们应对唑吡坦无副作用这一说法持怀疑态度,因为它可能会导致耐受性、滥用和戒断综合征。我们认为应改变其不加区分的使用方式。应仔细随访患者,并开具获取唑吡坦所需的医疗处方,而不是像目前这样无限制地获取。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验